Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04420819
Other study ID # FCT/UNESP
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date April 1, 2022

Study information

Verified date April 2022
Source Paulista University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Introduction: eccentric exercise (EE) has been widely used in rehabilitation and in improving physical fitness due to its mechanical advantage and less metabolic demand, however, EE can induce muscle damage providing structural changes and reduced muscle function, therefore, it is necessary to look for alternatives to reduce this damage caused by stress. Thus, ischemic preconditioning (PCI) can be seen as an aid in reducing the damage caused by EE, as it can attenuate the ischemia-reperfusion injury, and can be used to accelerate the post-exercise recovery process. Objectives: to compare the effects of PCI, using different occlusion pressures, on acute and late responses to perceptual outcomes and muscle injury markers, in addition to checking whether the technique causes deleterious effects on performance in post-exercise recovery. Methods: a randomized placebo controlled clinical trial will be conducted with 80 healthy men aged 18 to 35 years who will be randomly divided into four groups: PCI using total occlusion pressure (POT), PCI with 40% more than POT, placebo (10 mmHg) and control. The PCI protocol will consist of four cycles of ischemia and reperfusion of five minutes each. All groups will perform an EE protocol, initial assessments, immediately after the end of the EE, 24, 48, 72 and 96 hours after exercise, with the maximum isometric voluntary contraction (CVIM) assessed by the isokinetic dynamometer, vectors of cell integrity by by means of electrical bioimpedance (BIA), creatine kinase (CK), blood lactate, pain on the visual analog scale (VAS), pain threshold by the pressure algometer, and tone, muscle rigidity and elasticity by myotonometry. The descriptive statistical method and analysis of variance will be used for the repeated measures model. The level of significance will be p <0.05.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date April 1, 2022
Est. primary completion date December 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - not having any health condition that contraindicates or prevents EE; - not having diagnosed diabetes and high blood pressure; - not having inflammatory, psychiatric, cardiovascular and / or respiratory rheumatic disease; - not being an alcoholic, using drugs and / or a smoker; - without a history of knee surgery (for example, meniscal repair and ligament reconstruction) or recent musculoskeletal injury to the lower limbs that may impair performance during tests or interventions (for example, muscle injury, tendinopathy, patellofemoral pain in the lower limbs and / or back pain in the last six months); - without involvement in any type of training program during the study period; - not being engaged in the lower limb strength training program during the three months prior to participating in the study; - not using ergogenic supplements to improve physical performance and / or muscle mass and / or vasoactive drugs; - not having one or more risk factors predisposing to thromboembolism. Exclusion Criteria: - present a health problem that does not allow continuity, - use medication, electrotherapy or other therapeutic means that may interfere with any result; - perform unusual or strenuous physical activities during the evaluation period; - want to leave the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ischemic Preconditioning
The IPC is characterized by the application of brief periods of circulatory occlusion (ischemia) and reperfusion of a limb in the minutes to hours that precede the exercise through the insufflations and deflations of a pressure cuff

Locations

Country Name City State
Brazil Franciele Marques Vanderlei Presidente Prudente SP

Sponsors (1)

Lead Sponsor Collaborator
Paulista University

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle damage Plasma CK concentration will be obtained by means of 32 µL of capillary blood collected from the digital pulp. Change from baseline at 96 hours after exercise
Primary Blood lactate concentration Blood lactate concentration of the participant will be collected 25 ml of blood with an ear lobe capillary Change from baseline at 96 hours after exercise
Primary Muscle strength in isokinetic Maximal voluntary isometric contraction (MVIC) Change from baseline at 96 hours after exercise
Secondary Muscle pain Assessed using a visual analog scale that ranges from 0 to 10 points, the higher the score, the worse the result. Change from baseline at 96 hours after exercise
Secondary Pain threshold Assessed using pressure algometer equipment, and the pain threshold will be classified according to the cut-off point of 2.55kgf. Participants will be classified as "sensitive to pain" if they have values below 2.55kgf. Change from baseline at 96 hours after exercise
Secondary Resistance through Bioimpedance analysis (BIA) Evaluation of tissue resistance, the higher the value, the worse the result Change from baseline at 96 hours after exercise
Secondary Reactance through Bioimpedance analysis (BIA) Evaluation of tissue reactance, the higher the value, the better the cell integrity Change from baseline at 96 hours after exercise
Secondary Phase angle through Bioimpedance analysis (BIA) Assessment of the phase angle, the higher the value, the better the condition of the participant Change from baseline at 96 hours after exercise
Secondary Tone muscular through Myotonometry used the MyotonPRO equipment Natural Oscillation Frequency [Hz], characterizing Tone of the quadriceps femoris muscle Change from baseline at 96 hours after exercise
Secondary Stiffness through Myotonometry used the MyotonPRO equipment Dynamic Stiffness [N/m] of the quadriceps femoris muscle Change from baseline at 96 hours after exercise
Secondary Elasticity through Myotonometry used the MyotonPRO equipment Mechanical Stress Relaxation Time [ms] featuring muscle elasticity of the quadriceps femoris muscle Change from baseline at 96 hours after exercise
Secondary Perception of recovery Perception of recovery was obtained using a 10-point Likert Scale, with a rating of 1 indicating the feeling "not recovered" and a rating of 10 the feeling "fully recovered" Change from baseline at 96 hours after exercise
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1